Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.
about
Treatment for mitochondrial disordersTreatment for mitochondrial disordersStatin adverse effects : a review of the literature and evidence for a mitochondrial mechanismReplication-competent human mitochondrial DNA lacking the heavy-strand promoter regionA mitochondrial DNA variant, identified in Leber hereditary optic neuropathy patients, which extends the amino acid sequence of cytochrome c oxidase subunit IAn autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3pIs cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?Mitochondrial DNA disease-molecular insights and potential routes to a cureMechanism of homologous recombination and implications for aging-related deletions in mitochondrial DNAMitochondrial involvement in neurodegenerative diseasesmtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop regionMitochondrial DNA deletion mutations are concomitant with ragged red regions of individual, aged muscle fibers: analysis by laser-capture microdissection.Role of direct repeat and stem-loop motifs in mtDNA deletions: cause or coincidence?Correlation of the 4977 bp mitochondrial DNA deletion with human sperm dysfunction.The ophthalmologic manifestations of mitochondrial disease.Juvenile Kearns-Sayre syndrome initially misdiagnosed as a psychosomatic disorderThe mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer.A unique junctional palindromic sequence in mitochondrial DNA from a patient with progressive external ophthalmoplegia.Sequences with the potential to form stem-and-loop structures are associated with coding-region duplications in animal mitochondrial DNA.Repeats, longevity and the sources of mtDNA deletions: evidence from 'deletional spectra'.Association of mitochondrial DNA variations with lung cancer risk in a Han Chinese population from southwestern ChinaHuman mitochondrial genetics.Mitochondrial DNA deletions are associated with non-B DNA conformationsMitochondrial defects in neurodegenerative disease.Epidemiology and treatment of mitochondrial disorders.Linear mtDNA fragments and unusual mtDNA rearrangements associated with pathological deficiency of MGME1 exonuclease.Analysis of repeat-mediated deletions in the mitochondrial genome of Saccharomyces cerevisiaeThe somatic common deletion in mitochondrial DNA is decreased in schizophreniaMutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing.Stable nuclear expression of ATP8 and ATP6 genes rescues a mtDNA Complex V null mutantMaintenance of human rearranged mitochondrial DNAs in long-term cultured transmitochondrial cell lines.Mitochondrial DNA: impacting central and peripheral nervous systems.Increased frequency of deletions in the mitochondrial genome with age of Caenorhabditis elegans.Length heteroplasmies in human mitochondrial DNA control regions and breast cancer risk.The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility.Pedigree models for complex human traits involving the mitochondrial genome.Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant diseaseDefects of mitochondrial DNA.Disorders associated with multiple deletions of mitochondrial DNA.Multiple presentation of mitochondrial disorders
P2860
Q24200432-B8DCA36A-78C3-46DC-BE92-E73CB4BF94A8Q24244543-8AAC7DA6-1FB5-4A88-8BAE-4D82F9A691B3Q24603957-F4D197E0-DB33-4CC0-B3D3-D6DCB59A68BDQ24607395-485AD009-FC62-4A4B-9E58-D47887636812Q24670009-765871F8-617B-4B80-B87F-C5AE39E88D53Q24676151-DE173C48-E2DE-4D2F-9833-31B5A93120DFQ24791429-CC87792C-3B1D-4644-AF88-506C83F6C900Q27005350-FE151C10-AE9F-4415-BE34-81CB21D177BDQ27012566-8FBF0804-0E2C-47C3-A53D-8174A2D63C34Q27023940-5EED3E20-DDC8-430B-9155-2693BFBB1F74Q28762142-96DF93FE-8202-4FA1-A490-3AEF256905F3Q30760899-407A166E-BC46-4BA3-A1F9-B44831710B39Q31058320-2A441DF5-56FC-4615-B1AF-962B679C0C66Q33405486-789C243B-30CF-4A84-B527-4BC862858177Q33572038-5FAC6335-9B1A-43DE-A437-5383A3A94CDAQ33672801-075DAA5D-A9A3-4498-8FFC-931F2D3BB708Q33792617-6A1A032A-A272-4A18-B96F-845796FE3D38Q33918608-CF09CCE1-3AE1-4BBE-B590-0854AB60B326Q33962893-CC371270-8550-4475-8EC4-A02CD7EEE035Q34041483-52441DA1-A8E4-435E-901B-0DF56BC09E40Q34170799-8BAF7F15-6603-49E1-ACE6-07605DC868B0Q34187826-FFAB0DFA-6951-4A6D-AA33-CD14D52F14DAQ34278779-37FDF153-90B2-42DB-8FC0-CE281E91F80BQ34366678-F3EA4F0A-AEB1-46D5-96AF-4EB8EE27A728Q34386766-D03E6B51-040F-4316-9967-B8721A131B95Q34427479-C85640B3-F756-43FB-A12D-381279EA479FQ34586803-DA51CE48-9596-452B-9E75-1ED674020075Q34613536-A06EF3E0-FC1C-480D-82A6-1D2366B9F1E6Q34657233-9D77E773-4456-4A14-AFBF-516AF4A419B1Q34678611-55834DB9-9B3A-4810-959B-EC7A95DE7B9DQ34733032-70D40060-46DC-4AF5-BF08-EB18714DC832Q34737643-2AC84F54-A3CA-440C-BDB2-C44373912FACQ34747125-E433B920-0D7D-4B95-9747-C608E5DC2261Q34793943-38CEF54C-93A4-45F1-859C-BECCBF22A944Q34979054-233419C0-090C-4BA6-99F2-757AA8AA5923Q35195183-56A034E5-DE6D-4A0C-BAF0-A4AF78F10069Q35198608-4A4DCD85-C5D6-4240-AE36-784D8B763BDBQ35243825-2CCBFF69-B80F-47E4-A009-4D48E137BD95Q35243833-CCEF50AA-2E16-4C5F-9285-91C96CBC74F1Q35264537-30CE61E2-6878-4BCC-A280-35230CB1AE6E
P2860
Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@ast
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@en
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@nl
type
label
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@ast
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@en
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@nl
prefLabel
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@ast
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@en
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@nl
P2093
P2860
P356
P1476
Spontaneous Kearns-Sayre/chron ...... n model and metabolic therapy.
@en
P2093
A S Voljavec
D A Costigan
D C Wallace
J M Shoffner
S A Soueidan
P2860
P304
P356
10.1073/PNAS.86.20.7952
P407
P577
1989-10-01T00:00:00Z